Sabra Health Care REIT, Inc.
Every calculator, already run for SBRA
Open the full toolkit →You have the numbers on SBRA. Get the argument.
A written report on which of these readings actually decide the outcome for Sabra Health Care REIT, Inc., what has to stay true for the price to work, and the specific thing that would break it. The first one is free.
Key market data
Analyst consensus
16 analysts covering SBRAAnalyst Price Target Disagreement for Sabra Health Care REIT, Inc.
Wall Street's bull case implies +27% from the current price; the bear case implies -4%. A 30% spread signals high analyst disagreement — run your own DCF to anchor on fundamentals rather than street consensus.
Ownership & short interest
Insider Trading Activity for SBRA
| Insider | Role | Type | Shares | Price | Value | Date | Filing |
|---|---|---|---|---|---|---|---|
About Sabra Health Care REIT, Inc.
Sabra Health Care REIT, Inc. operates as a self-administered, self-managed real estate investment trust that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada. Sabra Health Care REIT, Inc. is incorporated on May 10th, 2010 and is based in Tustin, United States.
SBRA — frequently asked
Is SBRA a buy right now?
Wall Street's consensus rating on Sabra Health Care REIT, Inc. is Buy across 16 analysts, with a mean price target of $22.79 (+15% vs. the current $19.74). Ratings are a starting point — run the DCF and check the financial-health readings above before deciding.
Is SBRA overvalued?
SBRA trades at 75.9x trailing earnings, against a DCF fair value of $22 per share. The current price implies 5% annual free-cash-flow growth for a decade. Open the DCF or reverse-DCF tool to change the assumptions and see the range.
When is SBRA's next earnings date?
Sabra Health Care REIT, Inc. is next scheduled to report earnings around Nov 4, 2026. A full SBRA research report from Basis Report covers the setup into that print — estimates, the beat/miss record, and what would move the thesis.
What is the analyst price target disagreement for Sabra Health Care REIT, Inc.?
Analysts covering Sabra Health Care REIT, Inc. (SBRA) range from a bear-case target of $19.00 to a bull-case high of $25.00, with a mean consensus target of $22.79 across 14 analysts. The spread of $6.00 (30% of the current price) indicates high disagreement on the outlook. Run the DCF calculator to build your own estimate independent of street consensus.
Compare Sabra Health Care REIT, Inc. against related stocks
Explore additional stock overview pages and jump directly into full report generation for each symbol.
Sector peers
Most-followed names in the same sector.
Nearby tickers
Additional public equities from our tracked universe.
Market leaders
Large-cap symbols investors frequently compare.
Investor Guides For Sabra Health Care REIT, Inc.
Start with the evergreen guides that matter most for Real Estate, then move back into the ticker page when you want to pressure-test the framework on a live name.
Generate your full SBRA research report
DCF model, five-year financials, moat assessment, a BUY/HOLD/SELL rating, and the risks that matter — on Sabra Health Care REIT, Inc., in minutes. 3 free reports included with every account — no credit card required.